Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C-Reference-Cited by-同舟云学术

Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C

Published:2005-11 Issue:3 Volume:372 Page:171-181
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn Schmied Arch Pharmacol

Author:

Kassahun W. T.,Günl B.,Tannapfel A.,Ungemach F. R.,Hauss J.,Abraham G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-005-0017-2.pdf

Reference61 articles.

1. Abraham G, Kottke C, Dhein S, Ungemach FR (2003). Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract. Biochem Pharmacol 66:1067–1081

2. Benchekroun LE, Couton D, Postic C et al. (2005). Overexpression of β2-adrenergic receptors in mouse liver alters the expression of glyconeogenic and glycolytic enzymes. AJP-Endocrinol Metab 288:E715–E722

3. Bevilacqua M, Norbiato G, Chebat E et al (1991). Changes in alpha-1 and beta-2 adrenoceptor density in human hepatocellular carcinoma. Cancer 67:2543–2551

4. Bilski AJ, Halliday SE, Fitzgerald (1983). The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430–437

5. Brodde OE (1991). Beta1 and beta2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling;Acta Biochimica et Biophysica Sinica;2023-07-01

2. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients;Scandinavian Journal of Gastroenterology;2020-05-03

3. Neuroendocrine regulation of cholangiocarcinoma: A status quo review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2019-08

4. Expression and Functional Coupling of Liver ß2-Adrenoceptors in the Human Hepatocellular Carcinoma;Pharmacology;2012

5. Altered liver α1-adrenoceptor density and phospholipase C activity in the human hepatocellular carcinoma;European Journal of Pharmacology;2011-11